Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexia Kieffer is active.

Publication


Featured researches published by Alexia Kieffer.


PLOS Neglected Tropical Diseases | 2015

Estimating the global burden of endemic canine rabies.

Katie Hampson; Laurent Coudeville; Tiziana Lembo; Maganga Sambo; Alexia Kieffer; Michaël Attlan; Jacques Barrat; Jesse D. Blanton; Deborah J. Briggs; Sarah Cleaveland; Peter Costa; Conrad Martin Freuling; Elly Hiby; Lea Knopf; Fernando Leanes; F. X. Meslin; Artem Metlin; Mary Elizabeth Miranda; Thomas Müller; Louis Hendrik Nel; Sergio Recuenco; Charles E. Rupprecht; Carolin Schumacher; Louise H. Taylor; Marco Vigilato; Jakob Zinsstag; Jonathan Dushoff

Background Rabies is a notoriously underreported and neglected disease of low-income countries. This study aims to estimate the public health and economic burden of rabies circulating in domestic dog populations, globally and on a country-by-country basis, allowing an objective assessment of how much this preventable disease costs endemic countries. Methodology/Principal Findings We established relationships between rabies mortality and rabies prevention and control measures, which we incorporated into a model framework. We used data derived from extensive literature searches and questionnaires on disease incidence, control interventions and preventative measures within this framework to estimate the disease burden. The burden of rabies impacts on public health sector budgets, local communities and livestock economies, with the highest risk of rabies in the poorest regions of the world. This study estimates that globally canine rabies causes approximately 59,000 (95% Confidence Intervals: 25-159,000) human deaths, over 3.7 million (95% CIs: 1.6-10.4 million) disability-adjusted life years (DALYs) and 8.6 billion USD (95% CIs: 2.9-21.5 billion) economic losses annually. The largest component of the economic burden is due to premature death (55%), followed by direct costs of post-exposure prophylaxis (PEP, 20%) and lost income whilst seeking PEP (15.5%), with only limited costs to the veterinary sector due to dog vaccination (1.5%), and additional costs to communities from livestock losses (6%). Conclusions/Significance This study demonstrates that investment in dog vaccination, the single most effective way of reducing the disease burden, has been inadequate and that the availability and affordability of PEP needs improving. Collaborative investments by medical and veterinary sectors could dramatically reduce the current large, and unnecessary, burden of rabies on affected communities. Improved surveillance is needed to reduce uncertainty in burden estimates and to monitor the impacts of control efforts.


PLOS Neglected Tropical Diseases | 2015

Correction: Estimating the global burden of endemic canine rabies.

Katie Hampson; Laurent Coudeville; Tiziana Lembo; Maganga Sambo; Alexia Kieffer; Michaël Attlan; Jacques Barrat; Jesse D. Blanton; Deborah J. Briggs; Sarah Cleaveland; Peter Costa; Conrad Martin Freuling; Elly Hiby; Lea Knopf; Fernando Leanes; F. X. Meslin; Artem Metlin; Mary Elizabeth Miranda; Thomas Müller; Louis Hendrik Nel; Sergio Recuenco; Charles E. Rupprecht; Carolin Schumacher; Louise H. Taylor; Marco Antonio; Natal Vigilato; Jakob Zinsstag; Jonathan Dushoff; Global Alliance for Rabies Control Partners for Rabies Prevention

There are a number of errors in Table 3. The table legend should read: Breakdown of economic costs of rabies by cluster in millions of USD. The headings for columns six, seven, and eight are incorrect. They should be in the following order: Dog vaccination, Dog population management, Livestock losses. Please see the correct Table 3 below. n n n nTable 3 n nBreakdown of economic costs of rabies by cluster in millions of USD.


PLOS Neglected Tropical Diseases | 2014

A Sero-epidemiological Study of Arboviral Fevers in Djibouti, Horn of Africa

Fred Andayi; Rémi N. Charrel; Alexia Kieffer; Hervé Richet; Boris Pastorino; Isabelle Leparc-Goffart; Ammar Abdo Ahmed; Fabrice Carrat; Antoine Flahault; Xavier de Lamballerie

Arboviral infections have repeatedly been reported in the republic of Djibouti, consistent with the fact that essential vectors for arboviral diseases are endemic in the region. However, there is a limited recent information regarding arbovirus circulation, and the associated risk predictors to human exposure are largely unknown. We performed, from November 2010 to February 2011 in the Djibouti city general population, a cross-sectional ELISA and sero-neutralisation-based sero-epidemiological analysis nested in a household cohort, which investigated the arboviral infection prevalence and risk factors, stratified by their vectors of transmission. Antibodies to dengue virus (21.8%) were the most frequent. Determinants of infection identified by multivariate analysis pointed to sociological and environmental exposure to the bite of Aedes mosquitoes. The population was broadly naïve against Chikungunya (2.6%) with risk factors mostly shared with dengue. The detection of limited virus circulation was followed by a significant Chikungunya outbreak a few months after our study. Antibodies to West Nile virus were infrequent (0.6%), but the distribution of cases faithfully followed previous mapping of infected Culex mosquitoes. The seroprevalence of Rift valley fever virus was 2.2%, and non-arboviral transmission was suggested. Finally, the study indicated the circulation of Toscana-related viruses (3.7%), and a limited number of cases suggested infection by tick-borne encephalitis or Alkhumra related viruses, which deserve further investigations to identify the viruses and vectors implicated. Overall, most of the arboviral cases predictors were statistically best described by the individuals housing space and neighborhood environmental characteristics, which correlated with the ecological actors of their respective transmission vectors survival in the local niche. This study has demonstrated autochthonous arboviral circulations in the republic of Djibouti, and provides an epidemiological inventory, with useful findings for risk mapping and future prevention and control programs.


PLOS ONE | 2013

2009 A(H1N1) Seroconversion Rates and Risk Factors among the General Population in Vientiane Capital, Laos

Alexia Kieffer; Phimpha Paboriboune; Pascal Crépey; Bruno Flaissier; Vimalay Souvong; Nicolas Steenkeste; Nicolas Salez; François-Xavier Babin; Christophe Longuet; Fabrice Carrat; Antoine Flahault; Xavier de Lamballerie

Objective To assess 2009 A(H1N1) seroconversion rates and their determinants within an unvaccinated population in Vientiane Capital, Laos. Methods CoPanFlu Laos, a general population cohort of 807 households and 4,072 participants was established in March 2010. Sociodemographic data, epidemiological data, and capillary blood samples were collected from all the household members in March, and again in October 2010, in order to assess the level of antibodies to 2009 A(H1N1) with the haemagglutination inhibition assay. 2009 A(H1N1) seroconversion was defined as a fourfold or greater increase in titre between inclusion and follow-up. Determinants for pandemic influenza infection were studied using the generalized estimating equations model, taking household clustering into account. Results Between March and November 2010, 3,524 paired sera were tested. Prior to the pandemic, our cohort was almost completely vaccine-naive for seasonal influenza. The overall seroconversion rate among nonvaccinated individuals (nu200a=u200a2,810) was 14.3% (95%CI [13.0, 15.6]), with the highest rate for participants under 20 yo (19.8%, 95%CI [17.4, 22.4]) and the lowest rate for participants over 60 yo (6.5%, 95%CI [3.7, 10.4]). Participants with lower baseline titres had significantly higher infection rates, with a dose-effect relationship. Odds ratios (ORs) ranged from 76.5 (95%CI [27.1, 215.8]), for those with a titre at inclusion of 1∶10, to 8.1 (95%CI [3.3, 20.4]), for those with a titre of 1∶40. Having another household member with a titre ≥1∶80 was associated with a higher likelihood of immunity (ORu200a=u200a3.3, 95%CI [2.8, 3.9]). Conclusion The determinants and age distribution for seroconversion within a vaccine-naive population were similar to those found in developed countries. This pandemic was characterized by strong epidemiological determinants, regardless of geographical zone and level of development. Moreover, we detected pre-existing cross-reacting antibodies in participants over 60 yo, which could not have originated from former multiple vaccination as has been suggested elsewhere.


Virology Journal | 2014

Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents - A CoPanFlu cross-sectional study

Fred Andayi; Pascal Crépey; Alexia Kieffer; Nicolas Salez; Ammar A Abdo; Fabrice Carrat; Antoine Flahault; Xavier de Lamballerie

BackgroundFollowing the 2009 swine flu pandemic, a cohort for pandemic influenza (CoPanFlu) study was established in Djibouti, the Horn of Africa, to investigate its case prevalence and risk predictors’ at household level.MethodsFrom the four city administrative districts, 1,045 subjects from 324 households were included during a face-to-face encounter between 11th November 2010 and 15th February 2011. Socio-demographic details were collected and blood samples were analysed in haemagglutination inhibition (HI) assays. Risk assessments were performed in a generalised estimating equation model.ResultsIn this study, the indicator of positive infection status was set at an HI titre ofu2009≥u200980, which was a relevant surrogate to the seroconversion criterion. All positive cases were considered to be either recent infections or past contact with an antigenically closely related virus in humans older than 65 years. An overall sero-prevalence of 29.1% and a geometrical mean titre (GMT) of 39.5% among the residents was observed. Youths, ≤ 25 years and the elderly, ≥65xa0years had the highest titres, with values of 35.9% and 29.5%, respectively. Significantly, risk was high amongst youthsu2009≤u200925 years, (OR 1.5-2.2), residents of District 4(OR 2.9), students (OR 1.4) and individuals living near to river banks (OR 2.5). Belonging to a large household (OR 0.6), being employed (OR 0.5) and working in open space-outdoor (OR 0.4) were significantly protective. Only 1.4% of the cohort had vaccination against the pandemic virus and none were immunised against seasonal influenza.ConclusionDespite the limited number of incident cases detected by the surveillance system, A(H1N1)pdm09 virus circulated broadly in Djibouti in 2010 and 2011. Age-group distribution of cases was similar to what has been reported elsewhere, with youths at the greatest risk of infection. Future respiratory infection control should therefore be tailored to reach specific and vulnerable individuals such as students and those working in groups indoors. It is concluded that the lack of robust data provided by surveillance systems in southern countries could be responsible for the underestimation of the epidemiological burden, although the main characteristics are essentially similar to what has been observed in developed countries.


PLOS ONE | 2018

Protecting children from rabies with education and pre-exposure prophylaxis: A school-based campaign in El Nido, Palawan, Philippines

Raffy Deray; César Rivera; Shiela Gripon; Corazon Ulanday; Maria Concepcion Roces; Anna Charinna B. Amparo; Michaël Attlan; Clarisse Demont; Alexia Kieffer; Mary Elizabeth Miranda

Background Rabies remains endemic in the Philippines. A study was conducted in El Nido, Palawan, Philippines to: (i) detect the true incidence of animal bites in school children aged 5–14 years using active surveillance and compare these data to estimates from the existing passive surveillance system, (ii) evaluate the impact of rabies prevention education and pre-exposure prophylaxis (PrEP) on animal bite incidence, and (iii) assess the health economic impact of the interventions. Methodology and principal findings A cohort of 4,700 school children was followed-up for any suspect rabies exposures between January 2011 and December 2012. Data on animal bite incidence from the study cohort were compared to that obtained from a review of consultation records at the Animal Bite Treatment Center (ABTC). PrEP was offered to children in all 27 public elementary schools in El Nido (in January to February 2012). Teachers were given a manual for integrating rabies in the public elementary school curriculum during the school year 2012–13. Active surveillance of the cohort revealed a higher incidence of suspect rabies exposures than that from passive surveillance. Despite a decrease in the number of Category III bites, there was no significant decrease in overall bite incidence as a result of the interventions. However, there was an increase in rabies awareness among school children in all grade levels. There was also a high level of acceptability of PrEP. Children who received PrEP and subsequently were bitten only needed two booster doses for post-exposure prophylaxis, resulting in substantial cost-savings. Conclusions/significance The true burden of animal bites remains underestimated in ABTC records. PrEP is advantageous in selected population groups, i.e. school-aged children in rabies endemic areas with limited access to animal and human rabies prevention services. Educating school children is beneficial. Strengthening veterinary interventions to target the disease at source is important.


BMC Health Services Research | 2018

Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014

Sabine Tong; Caroline Amand; Alexia Kieffer; Moe H. Kyaw

BackgroundPneumonia is the leading cause of morbidity and mortality worldwide. Pneumococcal conjugate vaccines have reduced the burden of pneumonia, but data on the current burden of pneumonia and its impact on the healthcare system are needed to inform the development and use of new vaccines and other preventive measures.MethodsWe retrospectively analyzed the frequency of pneumonia in the US during 2008–2014 using data from the MarketScan® Commercial Claims and Encounters database. Frequencies of healthcare utilization related to the index pneumonia episode were calculated using the annual number of enrolled person-years (PY) as the denominator and the number of individuals with pneumonia as the numerator. Pneumonia-associated costs were calculated as mean payment per episode during the 2xa0years from 2013 to 2014.ResultsThe overall annual healthcare utilization rate for pneumonia was 15.1 per 1000 PY and decreased slightly from 2008 to 2014 (from 15.4 to 13.5 per 1000 PY). Most pneumonia-related healthcare utilization was due to office/outpatient visits (10.3 per 1000 PY; 68.3%). Emergency department/urgent care visits (2.5 per 1000 PY; 16.9%) and hospitalizations (2.2 per 1000 PY; 14.8%) contributed less. Pneumonia-related healthcare utilization was highest in children <u20095xa0years (rate per 1000 PYu2009=u200929.7 for <u20091xa0year, 47.9 for 1xa0year, and 39.5 for 2–4xa0years) and adults >u200965xa0years (45.0 per 1000 PY). The mean cost per pneumonia episode (95% confidence interval) was US


BMC Health Services Research | 2018

Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis

Caroline Amand; Sabine Tong; Alexia Kieffer; Moe H. Kyaw

429.1 (


BMC Health Services Research | 2018

Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008–2014

Sabine Tong; Caroline Amand; Alexia Kieffer; Moe H. Kyaw

424.8–


Field Actions Science Reports. The journal of field actions | 2012

HIV Viral Load Testing in Laos

Phimpha Paboriboune; S. Ngin; Alexia Kieffer; C. Phimphachanh; B. Bouchard; P. Ho Fan; Nicolas Steenkeste; G. Viretto; M Fernandez; Christophe Longuet; François-Xavier Babin; E. Nerrienet

433.4) for office/outpatient visits,

Collaboration


Dive into the Alexia Kieffer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mary Elizabeth Miranda

Research Institute for Tropical Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. X. Meslin

World Health Organization

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fred Andayi

Aix-Marseille University

View shared research outputs
Researchain Logo
Decentralizing Knowledge